Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

Funding and backers

Total raised
$37M
2 rounds on record
Latest round
$26M
Series A · May 2024 · 2 yr ago
Team
15
US Form 5500 (plan participants) · Dec 2025 · -6% in a year
Hiring now
3
open roles
Backers
3
Y Combinator, Radical Ventures
The money's age
Long since its last round
28 months since the last round · hiring slowed
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 14, 2024 Raised a round Series A $26M Dec 6, 2021 Raised a round Seed $11M · led by Khosla Ventures · Venturebeat Jun 2020 Went through Y Combinator
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Series A May 2024 $26M — streetinsider.com
Seed Dec 2021 $11M Khosla Ventures lead, Zetta Venture Partners lead Venturebeat
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Better medicine, fast.. Partner with us.
WoolaSeed $2.7M · 4 yr ago • Founded 2020 • 1-10 employees
A sustainable alternative to bubble wrap: protective e-commerce packaging made of leftover wool. Lightweight. Compostable. Customisable.
Arpelos designs multivalent medicines with transformative outcomes.
Firefly51-200 employees • 1 role
Firefly provides innovative and measurable mobility advertising solutions; from taxi/rideshare tops and wraps to LED trucks. We help brands…
BobaVenture round $65k · 4 yr ago • Founded 2018
Experience true "Freedom Together" with Boba's safe, ergonomic and stylish babywearing products. Our baby wraps, baby carriers and ring…
司由知名留美科学家舒晓正博士于2008年4月28日成立,是一家以自交联和生物模拟材料(Advanced Self-Crosslinked & Biomimetic Biomaterials)为技术平台,深耕临床医学和生物医药领域,具备自主研发能力的高新技术企业。致力于成为国内外新…

How Nabla Bio hires

Truth index
B 75/100
Ghost roles
0%
Stale roles
100%
Reposted roles
0%

Nabla Bio scores B on the Alion truth index (A is best, E worst), measured over 3 open roles re-checked against its own hiring board: 0% look like ghost listings, 100% have gone stale and 0% are the same role posted again. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed

Overview

Designing Better Medicines self.__wrap_n=self.__wrap_n||(self.CSS&&CSS.supports("text-wrap","balance")?1:2);self.__wrap_b=(e,n,t)=>{t=t||document.querySelector(`[data-br="${e}"]`);let r=t.parentElement,o=f=>t.style.maxWidth=f+"px";t.style.maxWidth="";let…

News

News pharmexec.com 4 days ago
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda PharmExec
Nabla Bio and Takeda enhance their partnership to revolutionize AI-driven protein therapeutics, aiming for groundbreaking advancements in drug development.
Read more
Report
News YahooFinance 12 months ago
Nabla Bio expands Takeda collab for protein therapeutics
The partnership will implement Nabla Bio
Read more
Report
News Pulse 2.0 2 years ago
Nabla Bio: Generative Protein Design Company Closes $26 Million In Series A
Generative protein design company Nabla Bio announced the closing of a $26 million Series A funding round, led by Radical Ventures with participation from all existing investors, and strategic collaborations with AstraZeneca, Bristol Myers Squibb Company,
Read more
Report
News Pulse 2.0 5 years ago
Antibody Design Company Nabla Bio Raises $11 Million In Funding
Nabla Bio - a next-generation antibody design company - announced that it closed an $11 million seed funding round. These are the details.
Read more
Report
News YahooFinance 5 years ago
Nabla Bio raises $11M for an "end-to-end" antibody design platform
Nabla Bio, a Boston, Massachusetts based startup, announced a $11 million seed round on Monday. The company, founded in May 2020, is looking to enter the increasingly competitive space of antibody design, and manufacturing. Nabla Bio, in essence, is an an
Read more
Report
News TechCrunch 5 years ago
Nabla Bio raises $11M for an "end-to-end" antibody design platform
Nabla Bio, a Boston, Massachusetts based startup, announced a $11 million seed round on Monday. The company, founded in May 2020, is looking to enter the
Read more
Report

Tech stack

The technologies known for Nabla Bio, by layer.
Languages
Python
JavaScript
TypeScript
Frameworks & libraries
PyTorch
React.js
Cloud & platforms
Kubernetes
Developer tools
Docker
SLURM
Practices & domains
HPC
Edge AI
Sign in to see how your skills match this stack Sign In

Growth

Hiring Momentum
28/100
Slowing
Open positions
3
0 opened / 0 closed in 30 days
ATS activity
Every ~2 days
09/29/2026
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
AI/ML
100% ▼

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Cambridge
Cambridge United States
Engineering / R&D
3 open roles 100% engineering 1-10 est. staff
hires for AI/ML
seen since Aug 2025 job postings

Jobs

≈ $144k – $272k per year (Estimated) • In office • Full-Time • 5+ years exp • Cambridge
Python
JavaScript
TypeScript
Edge AI
Frontend
React.js
DevOps
Docker
Kubernetes
Apply
≈ $138k – $261k per year (Estimated) • In office • Full-Time • 5+ years exp • Cambridge
Python
PyTorch
DevOps
HPC
Apply
≈ $129k – $246k per year (Estimated) • In office • Full-Time • 4+ years exp • Cambridge
Python
PyTorch
DevOps
SLURM
Kubernetes
HPC
Apply

Financials

Total raised
$37M
Latest round
Series A
Funding rounds
2
Funding rounds
Round Announced Amount
Series A 2024 $26M Details
Seed 2021 $11M Details